Demystifying Biosimilars: Development, Regulation and Clinical Use

Future Oncology - United Kingdom
doi 10.2217/fon-2018-0680
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Regulatory Considerations of Biosimilars and Clinical Dilema of Their Use

SANAMED
2017English

Demystifying Colour Regulation in Art – Protecting Substances, Appearances and Beyond

2020English

Demystifying Cognitive Flexibility: Implications for Clinical and Developmental Neuroscience

Trends in Neurosciences
Neuroscience
2015English

Pcn226 - Biosimilars and the Regulation of Oncological Preparations in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Sugammadex: Clinical Development and Practical Use

Korean Journal of Anesthesiology
AnesthesiologyPain Medicine
2013English

Demystifying Inhaler Use in Chronic Obstructive Airways Disease

Barcelona Respiratory Network
2018English

Recommendations for the Regulation of Biosimilars and Their Implementation in Latin America

GaBI Journal
Drug GuidesPharmacy
2014English

Biosimilars

ESMO Open
Cancer ResearchOncology
2018English

Quantifying Blood Flow Dynamics During Cardiac Development: Demystifying Computational Methods

Philosophical Transactions of the Royal Society B: Biological Sciences
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy